282 related articles for article (PubMed ID: 23097179)
1. Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.
Isaac C; Wright A; Usas A; Li H; Tang Y; Mu X; Greco N; Dong Q; Vo N; Kang J; Wang B; Huard J
J Orthop Res; 2013 Mar; 31(3):343-9. PubMed ID: 23097179
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
3. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
[TBL] [Abstract][Full Text] [Related]
4. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
[TBL] [Abstract][Full Text] [Related]
5. Aberrant RhoA activation in macrophages increases senescence-associated secretory phenotypes and ectopic calcification in muscular dystrophic mice.
Mu X; Lin CY; Hambright WS; Tang Y; Ravuri S; Lu A; Matre P; Chen W; Gao X; Cui Y; Zhong L; Wang B; Huard J
Aging (Albany NY); 2020 Dec; 12(24):24853-24871. PubMed ID: 33361519
[TBL] [Abstract][Full Text] [Related]
6. Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice.
Sohn J; Lu A; Tang Y; Wang B; Huard J
Hum Mol Genet; 2015 Jul; 24(13):3814-29. PubMed ID: 25859011
[TBL] [Abstract][Full Text] [Related]
7. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of FGF-21 Negatively Affects Bone Homeostasis in Dystrophin/Utrophin Double Knockout Mice.
Li H; Sun H; Qian B; Feng W; Carney D; Miller J; Hogan MV; Wang L
J Bone Miner Res; 2020 Apr; 35(4):738-752. PubMed ID: 31800971
[TBL] [Abstract][Full Text] [Related]
10. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
[TBL] [Abstract][Full Text] [Related]
11. Muscle structure influences utrophin expression in mdx mice.
Banks GB; Combs AC; Odom GL; Bloch RJ; Chamberlain JS
PLoS Genet; 2014 Jun; 10(6):e1004431. PubMed ID: 24922526
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
13. Improved Bone Quality and Bone Healing of Dystrophic Mice by Parabiosis.
Li H; Lu A; Gao X; Tang Y; Ravuri S; Wang B; Huard J
Metabolites; 2021 Apr; 11(4):. PubMed ID: 33923553
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
Gutpell KM; Hrinivich WT; Hoffman LM
PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
[TBL] [Abstract][Full Text] [Related]
15. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
[TBL] [Abstract][Full Text] [Related]
16. The absence of dystrophin rather than muscle degeneration causes acetylcholine receptor cluster defects in dystrophic muscle.
Kong J; Yang L; Li Q; Cao J; Yang J; Chen F; Wang Y; Zhang C
Neuroreport; 2012 Jan; 23(2):82-7. PubMed ID: 22124255
[TBL] [Abstract][Full Text] [Related]
17. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
Ito M; Ehara Y; Li J; Inada K; Ohno K
Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
[TBL] [Abstract][Full Text] [Related]
18. Second-generation compound for the modulation of utrophin in the therapy of DMD.
Guiraud S; Squire SE; Edwards B; Chen H; Burns DT; Shah N; Babbs A; Davies SG; Wynne GM; Russell AJ; Elsey D; Wilson FX; Tinsley JM; Davies KE
Hum Mol Genet; 2015 Aug; 24(15):4212-24. PubMed ID: 25935002
[TBL] [Abstract][Full Text] [Related]
19. RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice.
Mu X; Usas A; Tang Y; Lu A; Wang B; Weiss K; Huard J
FASEB J; 2013 Sep; 27(9):3619-31. PubMed ID: 23704088
[TBL] [Abstract][Full Text] [Related]
20. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
